Wharton' jelly mesenchymal stromal cell therapy for ischemic brain injury

Increasing evidence have supported that Wharton's jelly mesenchymal stem cell (WJ-MSCs) have immunomodulatory and protective effects against several diseases including kidney, liver pathologies, and heart injury. Few in vitro studies have reported that WJ-MSCs reduced inflammation in hippocampa...

Full description

Bibliographic Details
Main Authors: Kuo-Jen Wu, Seong-Jin Yu, Chia-Wen Chiang, Yu-Wei Lee, B Linju Yen, Chun-Sen Hsu, Li-Wei Kuo, Yun Wang
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Series:Brain Circulation
Subjects:
Online Access:http://www.braincirculation.org/article.asp?issn=2394-8108;year=2018;volume=4;issue=3;spage=124;epage=127;aulast=